Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory.
Tito R MendozaAjay SheshadriMehmet AltanKenneth HessGoldy GeorgeBettzy StephenLilibeth CastilloEnedelia RodriguezJing GongChristine PetersonJordi Rodon AhnertSiqing FuSarina A Piha-PaulShubham PantEcaterina DumbravaTimonthy A YapFilip JankuApostolia M TsimberidouVivek SubbiahDaniel D KarpAbdulrazzak ZarifaLacey M McQuinnCharles CleelandDavid S HongAung NaingPublished in: Journal for immunotherapy of cancer (2021)
In conclusion, the MDASI-Immunotherapy EPT is a valid, reliable, and sensitive tool for measuring symptomatic toxicity.